These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4135417)

  • 41. Induction of lymphocytic leukemia, lymphosarcoma, reticulum cell sarcoma, and osteogenic sarcoma in the Syrian golden hamster by oncogenic DNA simian virus 40.
    Diamandopoulos GT
    J Natl Cancer Inst; 1973 May; 50(5):1347-65. PubMed ID: 4351397
    [No Abstract]   [Full Text] [Related]  

  • 42. HL-A and lymphoid tumors.
    Dick FR; Fortuny I; Theologides A; Greally J; Wood N; Yunis EJ
    Cancer Res; 1972 Dec; 32(12):2608-11. PubMed ID: 4509228
    [No Abstract]   [Full Text] [Related]  

  • 43. SV40-induced transformation of cells of the lizard Gekko gecko.
    Clark HF; Jensen F; Defendi V
    Int J Cancer; 1972 May; 9(3):599-607. PubMed ID: 4350126
    [No Abstract]   [Full Text] [Related]  

  • 44. [Comparative immunogenicity of irradiated and nonirradiated syngeneic and xenogeneic tumor cells containing a common specific transplantation antigen].
    Kliuchareva TE; Kashkina LM; Deĭchman GI
    Biull Eksp Biol Med; 1978 Aug; 86(8):225-8. PubMed ID: 210867
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Loss or persistence of the differentiated state of simian virus 40-induced hamster tumor cells before and after serial passage in culture.
    Diamandopoulos GT; Miller MH; McLane MF; Evans PG
    Cancer Res; 1976 Sep; 36(9 pt.1):3171-7. PubMed ID: 184942
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antigenic modification of mammalian cells undergoing 'spontaneous' malignant conversion.
    Kieler J
    Ser Haematol; 1972; 5(4):93-122. PubMed ID: 4133765
    [No Abstract]   [Full Text] [Related]  

  • 47. PAPOVAVIRUS SV40: FAILURE TO ISOLATE INFECTIOUS VIRUS FROM TRANSFORMED HAMSTER CELLS SYNTHESIZING SV40-INDUCED ANTIGENS.
    MELNICK JL; KHERA KS; RAPP F
    Virology; 1964 Jul; 23():430-2. PubMed ID: 14194139
    [No Abstract]   [Full Text] [Related]  

  • 48. Tumor-specific transplantation antigen is expressed during SV40 lytic infection with wild-type and tsA mutant viruses.
    Anderson JL; Martin RG; Chang C; Mora PT
    Virology; 1977 Jan; 76(1):254-62. PubMed ID: 189492
    [No Abstract]   [Full Text] [Related]  

  • 49. Characterization of hamster antibody reacting with papovavirus SV40 tumor antigen.
    Tevethia S
    J Immunol; 1967 Jun; 98(6):1257-64. PubMed ID: 4290805
    [No Abstract]   [Full Text] [Related]  

  • 50. [Detection of specific T-antigens and T-antibodies in artificial heterogenization of tumors by SV40 virus].
    Belianchikova NI; Staroverova NS; Frol'tsova AE; Gamburg VP
    Vopr Virusol; 1973; 18(6):663-7. PubMed ID: 4364047
    [No Abstract]   [Full Text] [Related]  

  • 51. [Prevention of tumor growth by immunization of hamsters with x-irradiated SV40-transformed cells].
    Ashkenazi A; Zadik Z
    Harefuah; 1969 Nov; 77(9):376-9. PubMed ID: 4320099
    [No Abstract]   [Full Text] [Related]  

  • 52. Antigenic characteristics of tumors induced in Syrian hamsters by Simian virus 40.
    Kaliev Y
    Neoplasma; 1969 Jun; 16(3):285-91. PubMed ID: 4310748
    [No Abstract]   [Full Text] [Related]  

  • 53. Susceptibility and resistance to viral leukemogenesis in the mouse. IV. Mechanisms of host resistance to leukemia expression.
    Tennant JR
    J Natl Cancer Inst; 1972 Nov; 49(5):1257-67. PubMed ID: 4346533
    [No Abstract]   [Full Text] [Related]  

  • 54. Expression of fetal antigens and tumor-specific antigens in SV40-transformed cells. I. Serological analysis of the antigenic specificities.
    Ting CC; Ortaldo JR; Herberman RB
    Int J Cancer; 1973 Sep; 12(2):511-8. PubMed ID: 4134537
    [No Abstract]   [Full Text] [Related]  

  • 55. Studies on mice of a tumor resistant strain (X-Gf). 8. Type C particles in mammary tumors of Friend leukemia virus-infected mice.
    Goldfeder A; de Harven E; Friend C
    Rev Eur Etud Clin Biol; 1971 Apr; 16(4):323-8. PubMed ID: 4327596
    [No Abstract]   [Full Text] [Related]  

  • 56. Specific afferent interference by antiserum of in vivo immunity.
    Ting C; Herberman RB
    Nature; 1975 Oct; 257(5529):801-2. PubMed ID: 52846
    [No Abstract]   [Full Text] [Related]  

  • 57. Serum activity inhibiting specific simian virus 40-induced transplantation resistance and its correlation with primary SV40 tumors appearance in hamsters.
    Volpe EA
    Experientia; 1978 Jan; 34(1):113-6. PubMed ID: 202479
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cell-mediated immunity to Friend virus-induced leukemia.
    Ting CC; Shiu G; Rodrigues D; Herberman RB
    Cancer Res; 1974 Jul; 34(7):1684-7. PubMed ID: 4134674
    [No Abstract]   [Full Text] [Related]  

  • 59. Functional properties of T and B lymphocytes in cell-mediated immunity.
    Petrányl GG
    Haematologia (Budap); 1974; 8(1-4):361-82. PubMed ID: 4142621
    [No Abstract]   [Full Text] [Related]  

  • 60. Transplantation immunity to simian virus 40-transformed cells in tumor-bearing mice. II. Evidence for macrophage participation at the effector level of tumor cell rejection.
    Zarling JM; Tevethia SS
    J Natl Cancer Inst; 1973 Jan; 50(1):149-57. PubMed ID: 4348219
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.